85277-96-9

Upstream product

• 93605-81-3 1,2-dibromo-1-fluoro-2-phenyl-3-phthalimidopropane 
• 85277-78-7 ethyl (E)-3-fluoro-2-phenylacrylate 
• 85278-30-4 ethyl 2-(tert-butoxycarbonyl)-2-(bromodifluoromethyl)phenylacetate 
• 85277-62-9 ethyl 2-(tert-butoxycarbonyl)phenylacetate 
• 85278-32-6 ethyl 2-phenyl-3,3-difluoroacrylate 
• 16537-09-0 t-butyl phenylacetate 
• 136918-14-4 phthalimide 
• 85277-87-8 (E)-3-fluoro-2-phenyl-2-propen-1-ol 
• 85277-71-0 1-tert-butyl 3-ethyl 2-(difluoromethyl)-2-phenylmalonate 

Downstream Products

• 93605-81-3 1,2-dibromo-1-fluoro-2-phenyl-3-phthalimidopropane 
• 85278-05-3 (E)-3-fluoro-2-phenylallylamine hydrochloride 
• 879221-61-1 2-((Z)-2-Chloro-3-phenyl-allyl)-isoindole-1,3-dione 
• 93605-75-5 2-phenyl-3-fluoroallylamine 
• 85278-44-0 1-fluoro-2-phenyl-3-phthalimidopropene 
• 85278-84-8 (Z)-3-fluoro-2-phenyl-2-propenamine hydrochloride 
• 85278-69-9 (E)-2-phenyl-3-fluoroallyl alcohol 

Relevant academic research and scientific papers

Inactivation of bovine plasma amine oxidase by haloallylamines

Various 2- and 3-haloallylamines were synthesized and evaluated as inhibitors of the quinone-dependent bovine plasma amine oxidase (BPAO). 3-Haloallylamines, which were previously found to be good inhibitors of the flavin-dependent mitochondrial monoamine

Enzyme-activated irreversible inhibitors of monoamine oxidase: Phenylallylamine structure-activity relationships

Seventeen 2-aryl-3-haloallylamine derivatives were prepared and evaluated as inhibitors of monoamine oxidase (MAO, EC 1.4.3.4). The synthesis of these compounds was achieved from either α-methylstyrene or ring-substituted phenylacetic acid derivatives. Wi

Allyl amine MAO inhibitors

Compounds of the formula STR1 wherein: R is phenyl, phenyl monosubstituted, disubstituted, or trisubstituted by (C1 -C8) alkyl, (C1 -C8)alkoxy, hydroxy, chlorine, bromine, iodine, fluorine, trifluoromethyl, nitr